184 related articles for article (PubMed ID: 1825026)
1. Expression of the macrophage colony-stimulating factor and its receptor in gynecologic malignancies.
Baiocchi G; Kavanagh JJ; Talpaz M; Wharton JT; Gutterman JU; Kurzrock R
Cancer; 1991 Feb; 67(4):990-6. PubMed ID: 1825026
[TBL] [Abstract][Full Text] [Related]
2. Co-expression of M-CSF transcripts and protein, FMS (M-CSF receptor) transcripts and protein, and steroid receptor content in adenocarcinomas of the ovary.
Kommoss F; Wölfle J; Bauknecht T; Pfisterer J; Kiechle-Schwarz M; Pfleiderer A; Sauerbrei W; Kiehl R; Kacinski BM
J Pathol; 1994 Oct; 174(2):111-9. PubMed ID: 7965406
[TBL] [Abstract][Full Text] [Related]
3. Expression of transcripts for CSF-1 and for the "macrophage" and "epithelial" isoforms of the CSF-1R transcripts in human ovarian carcinomas.
Bauknecht T; Kiechle-Schwarz M; du Bois A; Wölfle J; Kacinski B
Cancer Detect Prev; 1994; 18(3):231-9. PubMed ID: 8076385
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
5. Ovarian adenocarcinomas express fms-complementary transcripts and fms antigen, often with coexpression of CSF-1.
Kacinski BM; Carter D; Mittal K; Yee LD; Scata KA; Donofrio L; Chambers SK; Wang KI; Yang-Feng T; Rohrschneider LR
Am J Pathol; 1990 Jul; 137(1):135-47. PubMed ID: 1695482
[TBL] [Abstract][Full Text] [Related]
6. M-CSF and M-CSF-receptor gene expression in acute myelomonocytic leukemias.
Parwaresch MR; Kreipe H; Felgner J; Heidorn K; Jaquet K; Bödewadt-Radzun S; Radzun HJ
Leuk Res; 1990; 14(1):27-37. PubMed ID: 2154646
[TBL] [Abstract][Full Text] [Related]
7. Serum level of macrophage colony-stimulating factor as a marker for gynecologic malignancies.
Suzuki M; Ohwada M; Sato I; Nagatomo M
Oncology; 1995; 52(2):128-33. PubMed ID: 7854772
[TBL] [Abstract][Full Text] [Related]
8. Colony-stimulating factor-1 and c-fms expression in human endometrial tissues and placenta during the menstrual cycle and early pregnancy.
Kauma SW; Aukerman SL; Eierman D; Turner T
J Clin Endocrinol Metab; 1991 Oct; 73(4):746-51. PubMed ID: 1832423
[TBL] [Abstract][Full Text] [Related]
9. Expression of the colony stimulating factor-1 receptor (c-fms product) by cells at the human uteroplacental interface.
Jokhi PP; Chumbley G; King A; Gardner L; Loke YW
Lab Invest; 1993 Mar; 68(3):308-20. PubMed ID: 8450649
[TBL] [Abstract][Full Text] [Related]
10. The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma.
Smith HO; Anderson PS; Kuo DY; Goldberg GL; DeVictoria CL; Boocock CA; Jones JG; Runowicz CD; Stanley ER; Pollard JW
Clin Cancer Res; 1995 Mar; 1(3):313-25. PubMed ID: 9815987
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of macrophage colony-stimulating factor (CSF-1) and its receptor, c-fms, in normal ovarian granulosa cells leads to cell proliferation and tumorigenesis.
Keshava N; Gubba S; Tekmal RR
J Soc Gynecol Investig; 1999; 6(1):41-9. PubMed ID: 10065425
[TBL] [Abstract][Full Text] [Related]
12. The cytokine CSF-1 (M-CSF) expressed by endometrial carcinomas in vivo and in vitro, may also be a circulating tumor marker of neoplastic disease activity in endometrial carcinoma patients.
Kacinski BM; Chambers SK; Stanley ER; Carter D; Tseng P; Scata KA; Chang DH; Pirro MH; Nguyen JT; Ariza A
Int J Radiat Oncol Biol Phys; 1990 Sep; 19(3):619-26. PubMed ID: 2145248
[TBL] [Abstract][Full Text] [Related]
13. Effect of all-trans-retinoic acid on c-fms proto-oncogene [colony-stimulating factor 1 (CSF-1) receptor] expression and CSF-1-induced invasion and anchorage-independent growth of human breast carcinoma cells.
Sapi E; Flick MB; Tartaro K; Kim S; Rakhlin Y; Rodov S; Kacinski BM
Cancer Res; 1999 Nov; 59(21):5578-85. PubMed ID: 10554038
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of the oncogene c-fms and its ligand, the macrophage colony-stimulating factor-1, in cervical cancer and the role of transforming growth factor-beta1 in inducing c-fms expression.
Kirma N; Hammes LS; Liu YG; Nair HB; Valente PT; Kumar S; Flowers LC; Tekmal RR
Cancer Res; 2007 Mar; 67(5):1918-26. PubMed ID: 17332318
[TBL] [Abstract][Full Text] [Related]
15. Macrophage colony-stimulating factor is expressed by an ovarian carcinoma subline and stimulates the c-myc proto-oncogene.
Krupitza G; Fritsche R; Dittrich E; Harant H; Huber H; Grunt T; Dittrich C
Br J Cancer; 1995 Jul; 72(1):35-40. PubMed ID: 7599064
[TBL] [Abstract][Full Text] [Related]
16. Colony-stimulating factor-1 and its receptor do not have a role in the pathogenesis of uterine sarcomas.
Anderson PS; Smith HO; Goldberg GL; Fields AL; Runowicz CD; Pollard JW
Gynecol Oncol; 1999 Aug; 74(2):202-7. PubMed ID: 10419732
[TBL] [Abstract][Full Text] [Related]
17. The biological effects of macrophage-colony-stimulating factor induced by progestin on growth and differentiation of endometrial adenocarcinoma cells.
Kimura T; Azuma C; Saji F; Tokugawa Y; Takemura M; Miki M; Ono M; Tanizawa O
Int J Cancer; 1991 Sep; 49(2):229-33. PubMed ID: 1831804
[TBL] [Abstract][Full Text] [Related]
18. The colony-stimulating factor 1 (CSF-1) receptor (c-fms proto-oncogene product) and its ligand.
Rettenmier CW; Roussel MF; Sherr CJ
J Cell Sci Suppl; 1988; 9():27-44. PubMed ID: 2978516
[TBL] [Abstract][Full Text] [Related]
19. Biological activity of the receptor for macrophage colony-stimulating factor in the human endometrial cancer cell line, Ishikawa.
Takeda S; Soutter WP; Dibb NJ; White JO
Br J Cancer; 1996 Mar; 73(5):615-9. PubMed ID: 8605095
[TBL] [Abstract][Full Text] [Related]
20. Messenger RNA decay of macrophage colony-stimulating factor in human ovarian carcinomas in vitro.
Chambers SK; Kacinski BM
J Soc Gynecol Investig; 1994; 1(4):310-6. PubMed ID: 9419789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
